Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $127.9b | $501.99 | -0.2% | 475.7K |
 REGN | Regeneron Pharmaceuticals Inc | $75.7b | $734.30 | +1.6% | 411.6K |
 INSM | Insmed, Inc. | $24.3b | $104.95 | +1.3% | 3.1M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.1b | $56.23 | -2.3% | 2.5M |
 KRYS | Krystal Biotech, Inc. Common Stock | $9.5b | $330.83 | -2.3% | 299.9K |
 CRSP | CRISPR Therapeutics AG | $5.4b | $54.16 | -5.9% | 2.4M |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 PGEN | Precigen, Inc. Common Stock | $3.1b | $7.58 | -2.5% | 4.7M |
 BEAM | Beam Therapeutics Inc. Common Stock | $2.5b | $25.52 | -1.7% | 2.2M |
 VCEL | Vericel Corporation | $2.1b | $40.03 | -2.5% | 576.0K |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.8b | $17.32 | -1.0% | 1.9M |
 BLFS | BioLife Solutions Inc. | $1.8b | $38.60 | 0.0% | N/A |
 NTLA | Intellia Therapeutics, Inc | $1.7b | $12.40 | -3.0% | 7.3M |
 QURE | uniQure N.V. | $1.6b | $23.14 | +1.1% | 2.5M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.5b | $4.58 | -2.2% | 2.7M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.0b | $10.60 | -3.1% | 774.3K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $24.77 | -1.2% | 349.1K |
 CYRX | CryoPort, Inc. Common Stock | $0.9b | $17.66 | -1.8% | 687.4K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.81 | -4.2% | 3.4M |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.8b | $11.96 | -3.3% | 568.2K |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.8b | $12.64 | -2.8% | 914.9K |
 SLDB | Solid Biosciences Inc. Common Stock | $0.7b | $6.92 | -2.0% | 978.1K |
 PRME | Prime Medicine, Inc. Common Stock | $0.5b | $3.55 | +9.0% | 11.6M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $1.46 | -3.0% | 4.4M |
 NGNE | Neurogene, Inc. Common Stock | $0.5b | $25.45 | -3.7% | 102.0K |
 RGNX | REGENXBIO Inc. | $490.5m | $7.63 | -3.9% | 1.0M |
 EDIT | Editas Medicine, Inc. Common Stock | $402.4m | $2.74 | -2.3% | 2.8M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $384.7m | $6.22 | -2.5% | 670.3K |
 IRD | Opus Genetics, Inc. Common Stock | $381.0m | $4.41 | +0.3% | 2.4M |
 OCGN | Ocugen, Inc. Common Stock | $345.9m | $1.05 | +0.5% | 4.9M |
 CABA | Cabaletta Bio, Inc. Common Stock | $339.1m | $2.02 | -2.6% | 3.6M |
 BNTC | Benitec Biopharma Inc. Common Stock | $313.2m | $9.00 | -2.5% | 199.2K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $289.8m | $3.31 | -2.6% | 1.4M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $287.6m | $5.06 | -1.8% | 1.2M |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $281.0m | $2.50 | -5.0% | 1.6M |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $209.5m | $5.42 | -1.1% | 266.8K |
 DTIL | Precision BioSciences, Inc. Common Stock | $174.2m | $6.21 | -1.9% | 174.1K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $151.0m | $2.47 | -0.2% | 560.5K |
 KRRO | Korro Bio, Inc. Common Stock | $142.0m | $9.77 | -2.0% | 129.0K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $130.8m | $0.66 | -4.6% | 1.0M |
 CBUS | Cibus, Inc. Class A Common Stock | $130.7m | $1.58 | -5.4% | 160.4K |
 ENGN | enGene Therapeutics Inc. Common Stock | $130.0m | $1.80 | -3.5% | 348.8K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $126.5m | $0.56 | -2.9% | 2.6M |
 INO | Inovio Pharmaceuticals, Inc. | $119.9m | $1.14 | -2.6% | 2.0M |
 GNLX | Genelux Corporation Common Stock | $115.8m | $2.54 | -2.3% | 76.5K |
 MXCT | MaxCyte, Inc. Common Stock | $110.4m | $1.05 | +0.9% | 317.8K |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 GRML | Greenland Mines Ltd. Common Stock | $60.0m | $6.42 | -13.8% | 4.7M |
 TIL | Instil Bio, Inc. Common Stock | $49.0m | $6.89 | -0.9% | 24.0K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $38.5m | $1.03 | -0.5% | 119.6K |